|
5iTech, LLC |
|
International Technology Capitalization & Commercialization |
|
Select technology companies founded and launched by 5iTech. |
|
Portfolio Companies |
|
|
|
Aria’s “signature” is generated through the simultaneous measurement of several chemical and physical attributes, so that complex industrial characteristics like “flavor” and “formulation” or medical diagnoses like “problem pregnancy” can be identified with this unique signature. |
|
Aria Analytics is commercializing a novel, patented, platform analytical technology to characterize liquids for industrial and medical uses. |
|
Nearly 500,000 patients have already been successfully treated using Oculatek methodology in outside the United States. Oculatek’s treatment approach has proven effective in treating eye strain and myopia and holds promise for effectively addressing presbyopia.
Oculatek is a joint effort between 5iTech; EST, Inc., a medical electronics design company of Solon, Ohio and JSC MACDEL, a medical device company headquartered in Moscow, Russia. |
|
Oculatek is bringing to market a line of therapeutic ophthalmology devices based on a new technology and methodology for treating disturbances of accommodation and refraction. Treatment approach is unique, simple and non-surgical. |
|
Aria devices provide information not available from any combination of other analytical methods. The technology differentiates liquids by generating and analyzing a unique acoustical mechanical “signature” during the drying process of a single drop sample. |